Amatuximab for High Mesothelin Cancers
A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers
Sponsor: National Cancer Institute (NCI)
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from National Cancer Institute (NCI)
Other Carcinoma, Non-Small-Cell Lung trials with similar outcome
A EARLY_PHASE1 clinical study on Carcinoma, Non-Small-Cell Lung and Carcinoma, Pancreatic Ductal, this trial is terminated or withdrawn. The trial is conducted by National Cancer Institute (NCI) and has accumulated 25 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
25 versions recorded-
Sep 2024 — Present [monthly]
Terminated EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated EARLY_PHASE1
-
Jan 2020 — Jan 2021 [monthly]
Terminated EARLY_PHASE1
-
Dec 2019 — Jan 2020 [monthly]
Terminated EARLY_PHASE1
▶ Show 20 earlier versions
-
Nov 2019 — Dec 2019 [monthly]
Terminated EARLY_PHASE1
-
Oct 2019 — Nov 2019 [monthly]
Terminated EARLY_PHASE1
-
Sep 2019 — Oct 2019 [monthly]
Terminated EARLY_PHASE1
-
Aug 2019 — Sep 2019 [monthly]
Terminated EARLY_PHASE1
-
Jul 2019 — Aug 2019 [monthly]
Terminated EARLY_PHASE1
-
Jun 2019 — Jul 2019 [monthly]
Terminated EARLY_PHASE1
-
May 2019 — Jun 2019 [monthly]
Terminated EARLY_PHASE1
-
Apr 2019 — May 2019 [monthly]
Terminated EARLY_PHASE1
-
Mar 2019 — Apr 2019 [monthly]
Terminated EARLY_PHASE1
-
Feb 2019 — Mar 2019 [monthly]
Terminated EARLY_PHASE1
-
Jan 2019 — Feb 2019 [monthly]
Terminated EARLY_PHASE1
-
Dec 2018 — Jan 2019 [monthly]
Terminated EARLY_PHASE1
-
Nov 2018 — Dec 2018 [monthly]
Terminated EARLY_PHASE1
-
Oct 2018 — Nov 2018 [monthly]
Terminated EARLY_PHASE1
-
Sep 2018 — Oct 2018 [monthly]
Terminated EARLY_PHASE1
-
Aug 2018 — Sep 2018 [monthly]
Terminated EARLY_PHASE1
-
Jul 2018 — Aug 2018 [monthly]
Terminated EARLY_PHASE1
-
Jun 2018 — Jul 2018 [monthly]
Terminated EARLY_PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Terminated EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Terminated Phase 0
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .